Chronic inflammation is involved in the development of colon cancer by inducing mutations and aberrant DNA methylation in colon epithelial cells. Furthermore, there is growing evidence that colonic microbiota modulates the inflammation response in the host and influences colon tumorigenesis. However, the influence of colonic microbiota on aberrant DNA methylation remains unknown. Here, we show the effect of colonic microbes on DNA methylation and tumorigenicity using a mouse model of human ulcerative colitis. Mice treated with azoxymethane (AOM) and dextran sulfate sodium (DSS) showed an increase in degree of colitis, as estimated by body weight, occult blood, and stool consistency/diarrhea at 2 weeks after treatment, but treatment with antibiotics markedly reduced the severity of the colitis. Although mucosal hyperplasia and increased inflammation-related genes were observed in the colonic epithelial cells of the AOM/DSS-treated mice, treatment with antibiotics abrogated these changes. In addition, treatment with antibiotics significantly decreased the number of mucosal nodules from 5.9 ± 5.3 to 0.2 ± 0.6 (P < .01) and area of occupancy from 50.1 ± 57.4 to 0.5 ± 1.4 mm 2 (P < .01). Aberrant DNA methylation of three marker CpG islands (Cbln4, Fosb, and Msx1) was induced by AOM/DSS treatment in colonic mucosae, but this increase was suppressed by 50%-92% (P < .05) with antibiotic treatment. Microbiome analysis showed that this change was associated with a decrease of the Clostridium leptum subgroup. These data indicate that antibiotics suppressed tumorigenesis through inhibition of aberrant DNA methylation induced by chronic inflammation.
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| INTRODUC TI ON
Chronic inflammation is involved in the development of a variety of cancers, such as CAC, 1,2 gastric cancer, 3 and liver cancer. 4 It leads to the accumulation of mutations and epigenetic alterations in tissues, and ultimately to the development of cancers. 5, 6 Mechanistically, cell proliferation induced by persistent tissue damage leads to increased chance of mutations 7, 8 and acceleration of age-associated DNA methylation. 9, 10 Reactive oxygen species and reactive nitrogen intermediates are produced by inflammatory cells as well as by upregulation of inflammation-related genes within epithelial cells, and lead to DNA damage 11 and changes in activity of epigenetic regulators. 12 Micro RNA (miRNA) expression is also altered in response to inflammatory signals, leading to impaired DNA repair activity 13 and altered expression of epigenetic regulatory genes. 14, 15 Especially in the colon, chronic inflammation and resultant tumorigenesis are heavily influenced by the intestinal microbiota, 2, 16 which have been investigated mainly using mouse models. Effects of germ-free conditions or treatment with antibiotics on the decrease in tumor incidence potentially have a large impact on cancer prevention. 21, 22 The decreasing effect is considered to be mediated by decreased mutation frequency or levels of aberrant DNA methylation. However, how modulation of colonic microbiota influences levels of aberrant DNA methylation in colonic epithelial cells remains unknown. In the present study, we gave antibiotics to modulate colonic microbiota in a mouse colon cancer model induced by AOM and DSS, and examined the effects of the modulation on inflammation, DNA methylation induction, and colon tumorigenicity.
| MATERIAL S AND ME THODS

| Animals, treatment with antibiotics, and cancer induction experiments
Male BALB/c mice were purchased from Charles River Laboratories (Yokohama, Japan analysis. For gene expression analysis, the entire colon, including both mucosal and muscle layers, was used, and total RNA was isolated using ISOGEN (Nippon Gene, Tokyo, Japan).
| Estimation of inflammation
At 7 weeks of age, severity of inflammation was monitored by fecal consistency (0, normal; 2, loose stool; 4, diarrhea), bleeding (0, normal; 2, bloody feces; 4, blood around anus), and body weight loss after DSS treatment (0, <3%; 1, 3%; 2, 6%; 3, 9%; 4, >12%). Disease activity index (DAI; from 0 to 12) was obtained as the total of three factors.
| Histological analysis
Histopathological changes in the colon were analyzed by H&E staining of 4-μm sections. Degree of infiltration of neutrophils and plasma cells was used as an indicator of active inflammation. Mucosal nodules were microscopically examined and categorized as dysplasia, adenoma, or adenocarcinoma.
| Direct DNA sequencing
Sequence variations at the Ctnnb1 exon 2 were detected by amplification of this locus using 20 ng template DNA with primers listed in Table S1 . The PCR product was purified using a DNA Clean and Concentrator Kit (Zymo Research, Irvine, CA, USA) and direct cycle sequenced using the Applied Biosystems Big Dye Terminator V3.1 (Thermo Fisher Scientific, Waltham, MA, USA). The sequences were determined with an Applied Biosystems 3130xl Genetic Analyzer (Thermo Fisher Scientific).
| Quantitative reverse transcription PCR
Complementary DNA was synthesized from DNase-treated total RNA (2 μg) using Olido-dT 20 (Thermo Fisher Scientific) and Superscript III reverse transcriptase (Thermo Fisher Scientific). Number of cDNA molecules was quantified by qRT-PCR. Primer sequences and PCR conditions are shown in Table S1 . The copy number of each sample was calculated by comparing the amplification curve with those of standard DNA samples of known copy numbers. Number of target cDNA molecules was normalized to that of Gapdh cDNA molecules.
| Quantitative methylation-specific PCR
BamHI-digested genomic DNA (1 μg) was treated with sodium bisulfite as described previously. 24 Bisulfite-treated DNA was resuspended in 40 μL TE, and 1 μL was used for quantitative PCR using primers specific to methylated target loci and B2 SINE repeat (Table   S1 ). DNA methylation levels were expressed as the percentage of 
| Fecal DNA extraction and microbe analysis
Feces were collected at 6 and 7 weeks of age and fecal DNA was extracted using QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA, USA). Fecal DNA was amplified by quantitative PCR (qPCR) using primers specific to the 16S rDNA gene for each group of bacteria species. 25, 26 Quantities of each bacteria group were normalized to the number of major bacteria which was amplified by primers for the 16S V2-V3 region. 27 Primer sequences and PCR conditions are shown in Table S2 . To calculate the absolute number of bacteria, the amplification curve of a sample was compared with those of a standard DNA sample of known bacterial numbers.
| Statistical analysis
To evaluate significance in differences in degree of colitis, number of tumors, area of occupancy of tumors, and DNA methylation levels, the Mann-Whitney U test was used using SPSS 13.0J (SPSS Japan Inc., Tokyo, Japan). Differences in mean expression levels and the number of colonic microbiota were analyzed by the Student's t test.
Relationships between the number of mucosal nodules, severity of inflammation, level of DNA methylation, and colonic microbiota were estimated by Pearson correlation analysis.
| RE SULTS
| Alleviation of colitis by treatment with antibiotics
Azoxymethane was given to 5-week-old male mice, followed by 1-week treatment with DSS with or without antibiotics (vancomycin, neomycin, metronidazole, ciprofloxacin) ( Figure 1A ). At 7 weeks of age, degree of colitis was monitored by fecal consistency, bleeding, and body weight loss. Fecal consistency and bleeding were significantly affected by giving AOM/DSS, but body weight was not ( Figure 1B ). Fecal consistency and bleeding tended to be alleviated by treatment with antibiotics (P = .08 for fecal consistency, and P = .21 for bleeding) ( Figure 1B ). Ten mice (Abx+) were treated with antibiotics in addition to receiving AOM/DSS. Feces were collected at 6 and 7 weeks of age. Severity of inflammation at 7 weeks of age was monitored by disease activity index (DAI). All mice were killed at 15 weeks of age. B, Severity of inflammation at 7 weeks of age monitored by fecal consistency, bleeding, body weight loss, and disease activity index. AOM/DSSinduced inflammation was suppressed by treatment with antibiotics. Bold horizontal bars indicate the average. **P < .01
| Suppression of mucosal hyperplasia and inflammation-associated gene expression by treatment with antibiotics
At 10 weeks after AOM/antibiotics treatment, microscopic changes of the colonic mucosae were examined. Consistent with previous reports, 20, 28, 29 diffuse mucosal hyperplasia was observed in the distal colon of AOM/DSS-treated mice. However, no or much less hyperplasia was observed in the colonic mucosae of mice treated with antibiotics ( Figure 2A) . Expression of Il1b, Il6, Il10, Nos2, and Tnf was increased in AOM/DSS-treated mice compared with non-treated mice. Treatment with antibiotics suppressed the increase in inflammation-related genes, especially Nos2 and Tnf ( Figure 2B ). These data showed that treatment with antibiotics alleviated colonic inflammation and reduced hyperplasia.
| Suppression of colon tumorigenesis by treatment with antibiotics
To analyze the effect of treatment with antibiotics on colon tumorigenesis, we calculated the number of mucosal nodules and area of F I G U R E 2 Mucosal histopathology and upregulation of inflammation-associated genes, and their suppression by antibiotics. A, Representative microscopic appearance of the colonic mucosae. At 10 weeks after treatment with azoxymethane (AOM)/antibiotics, adenomas/adenocarcinomas and diffuse mucosal hyperplasia were observed in mice without antibiotics (Abx−), but the appearance was suppressed in mice treated with antibiotics (Abx+). The middle photograph shows an adenoma with mucosal hyperplasia in an Abx− mouse. B, mRNA expression levels of inflammation-associated genes 10 weeks after treatment with AOM/antibiotics in colonic tissues. Upregulation of Nos2 and Tnf by AOM/dextran sulfate sodium (DSS) in the mice without antibiotics (Abx−) was not observed in mice with antibiotics (Abx+). Gene expression levels are shown as mean ± SD of 10 mice in each group. Il, interleukin; Ifng, interferon gamma; Nos, nitric oxide synthase; Tnf, tumor necrosis factor occupancy of nodules in the colon at 10 weeks after AOM/antibiotics treatment. Mucosal nodules were macroscopically observed in the distal region of the colon in 10 of the 10 mice treated with AOM/DSS without antibiotics ( Figure 3A ). In contrast, only one of the 10 mice treated with antibiotics had multiple mucosal nodules. Histopathologically, the mucosal nodules were identified as adenomas or adenocarcinomas; in addition, several sites of dysplasia were observed ( Table 1) . Sequence of the Ctnnb1 gene was analyzed for mutations, specifically in the regions of codons 32, 33, and 34, as adenocarcinomas induced by AOM/ DSS are known to display mutations in these sequences. 30 Two out of four adenocarcinomas tested were found to display these Ctnnb1 mutations (Table 1 and Figure S1 ). Average number of mucosal nodules was 6.0 in the mice without antibiotics treatment, but was almost zero in the antibiotics-treated mice ( Figure 3B ). Average of area of occupancy was 50 mm 2 in the mice without antibiotic treatment, and was significantly decreased, to almost zero, in mice treated with antibiotics ( Figure 3C ). These data clearly showed that antibiotics suppressed AOM/DSS-induced colon tumorigenesis.
| Inhibition of aberrant methylation induction by treatment with antibiotics
Effect of antibiotics treatment on DNA methylation in co- 
| Change of specific populations of colonic microbiota by treatment with antibiotics
We analyzed changes in the colonic microbiota by qPCR of bacterial 16S rDNA in the feces of the mice with and without antibiotic treatment before and after giving DSS. The number of major bacteria did not change with antibiotics treatment before DSS administration, but slightly increased after DSS administration ( Figure S1 ). Number of Clostridium leptum subgroup, anaerobic
Gram-positive bacteria, significantly decreased with antibiotics treatment both before and after DSS administration ( Figure 5 ), in agreement with the previous report. 20 The number of Lactobacillus group also decreased with antibiotics treatment after DSS administration ( Figure 5 ). In contrast, the number of Bacteroides fragilis group, anaerobic Gram-negative bacteria, increased with antibiotics treatment before DSS administration and with or without antibiotics after DSS administration ( Figure 5 ). These data showed that specific populations of microbiota were modulated by antibiotics treatment, and suggested that the changes to the microbiota led to a suppression of inflammation and methylation induction.
| Correlations between the number of mucosal nodules, DNA methylation levels, and colonic microbiota
Finally, we analyzed the relationships between the number of mucosal nodules, severity of colitis, DNA methylation levels in background epithelial cells, and colonic microbiota focusing only on AOM/DSS-treated mice not in mice treated with antibiotics. There was a significant degree of positive correlation (r = .82, P < .05) between the number of mucosal nodules and degree of colitis (DAI) F I G U R E 3 Decrease in the incidence of mucosal nodules with antibiotic treatment. A, Representative macroscopic appearance of the colon in the two groups. B, Number and area of mucosal nodules. Horizontal bars indicate the average. **P < .01. Colon mucosal nodules were induced by giving azoxymethane/dextran sulfate sodium (AOM/DSS), but this was suppressed by treatment with antibiotics, Abx, antibiotics that was monitored by fecal consistency, bleeding, and body weight loss ( Figure 6 ). A positive correlation was also observed with the levels of DNA methylation in colonic mucosae as observed at the Msx1 locus (r = .86, P < .01; Figure 6 ); a tendency toward elevated levels of DNA methylation was also observed at the Fobs locus (r = .68, P = .096). After DSS treatment only, number of the B. fragilis group showed a significant negative correlation (r = −.83, P < .01) whereas that of the Lactobacillus group showed a positive correlation (r = .73, P = .065) with the number of mucosal nodules ( Figure 6 ).
| D ISCUSS I ON
The Among the eight inflammation-associated genes analyzed in the present study, Nos2 expression was significantly repressed in mice treated with antibiotics, and Tnf tended to be repressed, in line with previous studies. 20, 32 Inducible nitric oxide synthase (iNOS) and tumor necrosis factor alpha (TNF-α) are known to be key mediators of colitis. Elevated TNF-α is associated with both human inflammatory bowel disease (IBD) and murine colitis, 33 and upregulation of iNOS is involved in human ulcerative colitis and murine colitis. 34, 35 In the mouse colitis model, epithelial cells have been found to show increased levels of Cox2 and Nos2 proteins, whereas inflammatory cells are known to express Tnf-α. 36, 37 At the same time, increased expression of Nos2 and Tnf are known to be associated with aberrant methylation induction, not only in the colon of DSS-treated mice but also in the stomach of Helicobacter pylori-infected Mongolian gerbils. 28, 31, 38, 39 Increased production of nitric oxide enhances enzymatic activity of DNA methyltransferases. 12 Thus, treatment with antibiotics was considered to suppress chronic inflammation characterized by Nos2 and Tnf elevation, and inhibit induction of aberrant methylation.
The number of C. leptum subgroup significantly decreased with antibiotics both before and after giving DSS, which was in line with a previous report 20 and suggested a role of the C. leptum subgroup in induction of inflammation and DNA methylation. In humans, the number of C. leptum subgroup was decreased in IBD patients, 40 but was not different between colon cancer patients and healthy volunteers. 41 In contrast, the number of B. fragilis group was increased by treatment with antibiotics before giving DSS and with or without antibiotics after DSS treatment. This suggested that it can contribute to inflammation and DNA methylation only in cooperation with the C. leptum subgroup. The promoting role of B. fragilis is supported by a study that subsequent risk of colorectal cancer increased among patients with bacteremia from B. fragilis, 42 and also by a study showing that enterotoxigenic B. fragilis triggered colon carcinogenesis in a mouse model. 43 Naturally, these bacteria include various genera and species, and a more detailed analysis is necessar y to identify bacteria that suppress colitis and aberrant DNA methylation.
The present study shows an indirect association of colonic microbiota with chronic inflammation. These findings can be further investigated by giving certain bacterial subgroups to mice; it has, however, been reported that the outcome of such a study may be influenced by conditions including bacterial strain, bacterial preparation, timing of dosage, and condition or state of the mouse. 44 Such a transplantation-based experiment would be required to show a direct causal relationship.
F I G U R E 5
Changes in colonic microbiota with antibiotic treatment. Cell numbers of bacteria belonging to the four groups in the feces collected before and after dextran sulfate sodium (DSS) administration. Number of bacteria was analyzed by qPCR using primers for the 16S rDNA of each type of bacteria species. Quantities of each bacteria group were normalized to the number of major bacteria. Treatment with antibiotics increased the quantity of Bacteroides fragilis group and decreased Clostridium leptum subgroup and Lactobacillus group. Number of bacteria is shown as mean ± SD of 10, nine, and 10 mice for non-treatment (NT), treatment without antibiotics (Abx−), and treatment with antibiotics (Abx+), respectively. **P < .01. AOM, azoxymethane Aberrant DNA methylation is known to be accumulated in noncancerous or precancerous tissues exposed to environmental factors, producing an "epigenetic field for cancerization". 45, 46 The level of epigenetic field for cancerization is a promising cancer risk marker, as evidenced by the multicenter prospective cohort study for metachronous gastric cancer. 47, 48 The present study also supported that this epigenetic marker is well associated with tumor development, and indicated that it is useful to monitor the effect of modulation of the intestinal microbiome.
In summary, antibiotics suppressed tumorigenesis by inhibiting aberrant DNA methylation induction by chronic inflammation.
Modulation of the intestinal microbiome targeting chronic inflammation represents a strategy to prevent chronic inflammationassociated cancers.
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